RP

Rigel Pharmaceuticals

RIGL
NASDAQHealth Care

Recent Patents

rigl
over 1 year ago

Filed a patent for "treatment of hematologic malignancies or pre-malignancies" on Fri, July 7, 2023

New US Patent
rigl
over 1 year ago

Filed a patent for "formulations and dosing regimens for rip1 kinase inhibitors for treating autoimmune and inflammatory diseases" on Mon, June 26, 2023

New US Patent
rigl
over 1 year ago

Filed a patent for "use of a syk inhibitor for the treatment of sickle cell disease" on Wed, March 1, 2023

New US Patent
rigl
over 1 year ago

Filed a patent for "use of a syk inhibitor for the treatment of chemical or radiation induced lung injury" on Wed, March 1, 2023

New US Patent
rigl
over 1 year ago

Filed a patent for "inhibitors of ret" on Thu, December 19, 2024

New US Patent
rigl
over 1 year ago

Filed a patent for "rip1 inhibitory compounds and methods for making and using the same" on Thu, November 7, 2024

New US Patent
rigl
almost 2 years ago

Filed a patent for "rip1 inhibitory compounds and methods for making and using the same" on Thu, July 4, 2024

New US Patent
rigl
almost 2 years ago

Filed a patent for "amide compounds and method for making and using" on Thu, April 13, 2023

New US Patent
rigl
almost 2 years ago

Filed a patent for "2,4-diamino-pyrimidine compounds and method for making and using the compounds" on Thu, March 30, 2023

New US Patent
rigl
almost 2 years ago

Filed a patent for "solid forms of pralsetinib" on Thu, September 21, 2023

New US Patent
rigl
almost 2 years ago

Filed a patent for "pralsetinib pharmaceutical compositions" on Thu, June 29, 2023

New US Patent
rigl
almost 2 years ago

Filed a patent for "rip1 inhibitory compounds and methods for making and using the same" on Thu, October 5, 2023

New US Patent
rigl
almost 2 years ago

Filed a patent for "heterocyclic rip1 inhibitory compounds" on Thu, May 11, 2023

New US Patent
rigl
almost 2 years ago

Filed a patent for "rip1k inhibitors" on Thu, July 20, 2023

New US Patent
rigl
almost 2 years ago

Filed a patent for "tricyclic irak inhibitors" on Thu, October 5, 2023

New US Patent
rigl
almost 2 years ago

Filed a patent for "rip1k inhibitors" on Thu, August 24, 2023

New US Patent
rigl
almost 2 years ago

Filed a patent for "method of preparing pralsetinib" on Thu, February 22, 2024

New US Patent
rigl
almost 2 years ago

Filed a patent for "rip1 inhibitory compounds and methods for making and using the same" on Thu, October 12, 2023

New US Patent
rigl
2 years ago

Filed a patent for "pyrimid-2-yl-pyrazole compounds as irak inhibitors" on Wed, March 23, 2022

New US Patent
rigl
2 years ago

Filed a patent for "tricyclic irak inhibitors" on Thu, March 31, 2022

New US Patent
rigl
2 years ago

Filed a patent for "pyrazole compounds, formulations thereof, and a method for using the compounds and/or formulations" on Thu, September 29, 2022

New US Patent
rigl
2 years ago

Filed a patent for "pyrazole compounds and methods for making and using the compounds" on Thu, September 15, 2022

New US Patent
rigl
2 years ago

Filed a patent for "bicyclic inhibitors of irak" on Wed, June 1, 2022

New US Patent
rigl
2 years ago

Filed a patent for "rip1 inhibitory compounds and methods for making and using the same" on Thu, April 13, 2023

New US Patent
rigl
2 years ago

Filed a patent for "rip1 inhibitory compounds and methods for making and using the same" on Thu, April 13, 2023

New US Patent
Cashu Markets
Cashu
Markets

By Cashu Markets. Providing market news, analysis, and research for investors worldwide.

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Markets is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Markets is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Markets and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Cashu Markets
Cashu
Markets

Setting up your session...